Drugs · Brain health technique
Metformin
Evidence grade: Context Dependent

An oral drug, metformin (Glucophage®, Riomet®, Fortamet®, Glumetza®), that lowers hepatic glucose output, improves peripheral insulin sensitivity, and activates cellular AMPK pathways.
- Practice
- Drugs
- Principle
- Treatment
- Tactic
- Metabolic & Vascular Optimization Drugs
- Health domains
- metabolic
- Evidence grade
- Context Dependent
- Strength of evidence
- Medium
- Cost
- High
- Effort
- Low
- Time commitment
- Low
How to practice Metformin
Take 500–2000 mg daily with meals under physician supervision. Start low and titrate slowly to minimize GI side effects. Monitor B12 annually. Most beneficial in insulin resistance, prediabetes, or metabolic syndrome. Avoid off-label longevity use without medical monitoring; benefits derive from metabolic normalization, not direct neuroprotection.
The evidence behind Metformin
Metformin is a diabetes drug that lowers blood sugar. In people with diabetes, strong observational data link metformin use to lower mortality. Metformin also changes how your cells make and use energy (acting on mitochondria) and is thought to lower oxidative stress.
Impact on brain health
The same data link metformin use in diabetes to lower dementia risk. Trials show mixed effects on memory and thinking: benefits mostly in people with insulin resistance, and no clear benefit in adults with normal metabolism.
Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science
More Drugs techniques
Pair this with other habits from the same practice.

Evidence grade: Context Dependent
Anti-Amyloid Monoclonal Antibodies
FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

Evidence grade: Context Dependent
Antihypertensives
Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

Evidence grade: Context Dependent
GLP-1 Receptor Agonists
A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.
Take control of your brain health
BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.